418 related articles for article (PubMed ID: 10702799)
21. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
[TBL] [Abstract][Full Text] [Related]
22. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
23. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors.
Argani P; Fritsch M; Kadkol SS; Schuster A; Beckwith JB; Perlman EJ
Mod Pathol; 2000 Jan; 13(1):29-36. PubMed ID: 10658907
[TBL] [Abstract][Full Text] [Related]
24. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
25. Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13).
Beverloo HB; Panagopoulos I; Isaksson M; van Wering E; van Drunen E; de Klein A; Johansson B; Slater R
Cancer Res; 2001 Jul; 61(14):5374-7. PubMed ID: 11454678
[TBL] [Abstract][Full Text] [Related]
26. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
27. Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.
Cetinbas N; Huang-Hobbs H; Tognon C; Leprivier G; An J; McKinney S; Bowden M; Chow C; Gleave M; McIntosh LP; Sorensen PH
J Biol Chem; 2013 Sep; 288(39):27940-50. PubMed ID: 23798677
[TBL] [Abstract][Full Text] [Related]
28. p210BCR/ABL, p190BCR/ABL, and TEL/ABL activate similar signal transduction pathways in hematopoietic cell lines.
Okuda K; Golub TR; Gilliland DG; Griffin JD
Oncogene; 1996 Sep; 13(6):1147-52. PubMed ID: 8808688
[TBL] [Abstract][Full Text] [Related]
29. Identification of a second Grb2 binding site in the v-Fms tyrosine kinase.
Mancini A; Niedenthal R; Joos H; Koch A; Trouliaris S; Niemann H; Tamura T
Oncogene; 1997 Sep; 15(13):1565-72. PubMed ID: 9380408
[TBL] [Abstract][Full Text] [Related]
30. Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.
Iijima Y; Okuda K; Tojo A; Tri NK; Setoyama M; Sakaki Y; Asano S; Tokunaga K; Kruh GD; Sato Y
Oncogene; 2002 Jun; 21(28):4374-83. PubMed ID: 12080468
[TBL] [Abstract][Full Text] [Related]
31. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.
Chakrabarti SR; Nucifora G
Biochem Biophys Res Commun; 1999 Nov; 264(3):871-7. PubMed ID: 10544023
[TBL] [Abstract][Full Text] [Related]
32. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.
McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
[TBL] [Abstract][Full Text] [Related]
33. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.
Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH
Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816
[TBL] [Abstract][Full Text] [Related]
34. Dimerization of the docking/adaptor protein HEF1 via a carboxy-terminal helix-loop-helix domain.
Law SF; Zhang YZ; Fashena SJ; Toby G; Estojak J; Golemis EA
Exp Cell Res; 1999 Oct; 252(1):224-35. PubMed ID: 10502414
[TBL] [Abstract][Full Text] [Related]
35. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of glutathione biosynthesis in NIH3T3 cells transformed with the ETV6-NTRK3 gene fusion.
Kim SJ; Kim HG; Lim HW; Park EH; Lim CJ
Mol Cells; 2005 Feb; 19(1):131-6. PubMed ID: 15750350
[TBL] [Abstract][Full Text] [Related]
37. ETV6: a versatile player in leukemogenesis.
Bohlander SK
Semin Cancer Biol; 2005 Jun; 15(3):162-74. PubMed ID: 15826831
[TBL] [Abstract][Full Text] [Related]
38. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs.
Matuoka K; Miki H; Takahashi K; Takenawa T
Biochem Biophys Res Commun; 1997 Oct; 239(2):488-92. PubMed ID: 9344857
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.
Qiao Y; Ogawa S; Hangaishi A; Yuji K; Izutsu K; Kunisato A; Imai Y; Wang L; Hosoya N; Nannya Y; Sato Y; Maki K; Mitani K; Hirai H
Leukemia; 2003 Jun; 17(6):1112-20. PubMed ID: 12764377
[TBL] [Abstract][Full Text] [Related]
40. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]